Effects of Cannabidiol (CBD) on a Fixed Dose of Delta-9-tetrahydrocannabinol (THC)

StatusNot Yet Recruiting
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 10 changed
See other at-risk trials from Johns Hopkins University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This study will evaluate the subjective and behavioral effects of cannabis products containing delta-9-tetrahydrocannabinol and cannabidiol
Trial Details
NCT Number NCT07870187
Lead Sponsor Johns Hopkins University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)		 Cannabis Intoxication
Related terms Marijuana Abuse
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov